41:I[185,["/_next/static/chunks/0sxns9k8ywops.js","/_next/static/chunks/1z5eijs5qdv02.js","/_next/static/chunks/2eylv_sshoiot.js","/_next/static/chunks/3owl5o1y-37u7.js","/_next/static/chunks/0agcep-t686m_.js","/_next/static/chunks/09e73exje0qtu.js","/_next/static/chunks/1nsk8jrr9fqe6.js"],"SendEmailButton"] 43:I[63625,["/_next/static/chunks/0sxns9k8ywops.js","/_next/static/chunks/1z5eijs5qdv02.js","/_next/static/chunks/2eylv_sshoiot.js","/_next/static/chunks/3owl5o1y-37u7.js","/_next/static/chunks/0agcep-t686m_.js","/_next/static/chunks/09e73exje0qtu.js","/_next/static/chunks/1nsk8jrr9fqe6.js"],"AddToLibraryButton"] 44:I[29721,["/_next/static/chunks/0sxns9k8ywops.js","/_next/static/chunks/1z5eijs5qdv02.js","/_next/static/chunks/2eylv_sshoiot.js","/_next/static/chunks/3owl5o1y-37u7.js","/_next/static/chunks/0agcep-t686m_.js","/_next/static/chunks/09e73exje0qtu.js","/_next/static/chunks/1nsk8jrr9fqe6.js"],"ShareButton"] 45:I[58016,["/_next/static/chunks/0sxns9k8ywops.js","/_next/static/chunks/1z5eijs5qdv02.js","/_next/static/chunks/2eylv_sshoiot.js","/_next/static/chunks/3owl5o1y-37u7.js","/_next/static/chunks/0agcep-t686m_.js","/_next/static/chunks/09e73exje0qtu.js","/_next/static/chunks/1nsk8jrr9fqe6.js"],"ProcessEpisodeButton"] 46:I[45269,["/_next/static/chunks/0sxns9k8ywops.js","/_next/static/chunks/1z5eijs5qdv02.js","/_next/static/chunks/2eylv_sshoiot.js","/_next/static/chunks/3owl5o1y-37u7.js","/_next/static/chunks/0agcep-t686m_.js","/_next/static/chunks/09e73exje0qtu.js","/_next/static/chunks/1nsk8jrr9fqe6.js"],"SignupCTA"] 3b:["$","div",null,{"className":"flex flex-wrap items-center gap-x-4 gap-y-1 font-mono text-[12px] uppercase tracking-[0.1em] text-[color:var(--fg-3)]","children":[["$","time",null,{"dateTime":"2025-11-07T00:00:00.000Z","children":"November 7, 2025"}],["$","span",null,{"aria-hidden":true,"children":"·"}],["$","span",null,{"children":"00:38:52"}],false]}] 42:T438,

Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells.

Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models.

From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to research the treatment of addiction disorders and inking a new agreement with Swiss based InSphero, Tessara Therapeutics is helping to unlock human neuroscience.

Joining us on the MTPConnect podcast is Tessara Therapeutics CEO and Managing Director, Dr Christos Papadimitriou to tell us more about their innovation to accelerate neural drug discovery and their plans to take this technology global.